QIAGEN Submits Companion Diagnostic, Investigational Lung Cancer Compound

Qiagen announced submission of its therascreen EGFR RGQ PCR Kit as a proposed companion diagnostic to guide treatment with afatinib, a new investigational oncology compound developed by Boehringer Ingelheim.
PR Newswire